![John Katzenellenbogen](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
John Katzenellenbogen
Corporate Officer/Principal chez University of Illinois
Postes actifs de John Katzenellenbogen
Sociétés | Poste | Début | Fin |
---|---|---|---|
University of Illinois | Corporate Officer/Principal | - | - |
Historique de carrière de John Katzenellenbogen
Anciens postes connus de John Katzenellenbogen
Sociétés | Poste | Début | Fin |
---|---|---|---|
RADIUS HEALTH, INC. | Fondateur | 03/10/2003 | - |
Corporate Officer/Principal | 03/10/2003 | - |
Formation de John Katzenellenbogen
Harvard University | Doctorate Degree |
Statistiques
Internationale
Etats-Unis | 4 |
Opérationnelle
Corporate Officer/Principal | 2 |
Founder | 1 |
Doctorate Degree | 1 |
Sectorielle
Consumer Services | 3 |
Health Technology | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
Entreprise privées | 1 |
---|---|
Radius Health, Inc.
![]() Radius Health, Inc. BiotechnologyHealth Technology Radius Health, Inc. is a biopharmaceutical company, which engages in developing and commercializing endocrine therapeutics in the areas of osteoporosis and oncology. The company’s lead product, Abaloparatide-SC, reduces fracture risk in postmenopausal women with osteoporosis. Its pipeline also includes the abaloparatide transdermal patch for potential use in osteoporosis, and RAD1901 for potential use in hormone-driven, or hormone-resistant, metastatic breast cancer, and vasomotor symptoms in postmenopausal women. The company was founded by John Katzenellenbogen, Stavros C. Manolagas, Michael Rosenblatt, and John T. Potts on October 3, 2003 and is headquartered in Boston, MA. | Health Technology |
- Bourse
- Insiders
- John Katzenellenbogen
- Expérience